10 replies on “WBAP – Learning From Legends (3rd July 2021)”
How to distinguish MAS in HLH only in context is JIA or other parameters
How long can we wait with MP alone in mild moderate MISC?
Sir
Thanks for an elaborate talk
– Which group would you recommend upfront intensification in KD; as the evidence for benefit in terms of reduction in CAA in a high-risk group is still not robust.
-Thoughts on upfront use of steroids as primary therapy in KD in place of IVIG, particularly for resource-poor settings.
Many patients are presenting with multi-organ involvement without fever. what might be the diagnosis?
Post covid K.D Immunoglobulin test which: Total;IgG;spilke protein from where?anylevel parameter?
Why there is low sodium in MIS-C?
What might be the incidence of MIS-C in 3rd wave as already the seroprevalence of pediatric covid is >50% in India?
What are the risk factors for ivig resistance?any recent experience?
Sir
Thanks for an elaborate talk
– Which group would you recommend upfront intensification in KD; as the evidence for benefit in terms of reduction in CAA in a high-risk group is still not robust.
-Thoughts on upfront use of steroids as primary therapy in KD in place of IVIG, particularly for resource-poor settings.
When to use Dexa or Methylprednisolone in HLH mgt?
DIAP India
10 replies on “WBAP – Learning From Legends (3rd July 2021)”
How to distinguish MAS in HLH only in context is JIA or other parameters
How long can we wait with MP alone in mild moderate MISC?
Sir
Thanks for an elaborate talk
– Which group would you recommend upfront intensification in KD; as the evidence for benefit in terms of reduction in CAA in a high-risk group is still not robust.
-Thoughts on upfront use of steroids as primary therapy in KD in place of IVIG, particularly for resource-poor settings.
Many patients are presenting with multi-organ involvement without fever. what might be the diagnosis?
Post covid K.D Immunoglobulin test which: Total;IgG;spilke protein from where?anylevel parameter?
Why there is low sodium in MIS-C?
What might be the incidence of MIS-C in 3rd wave as already the seroprevalence of pediatric covid is >50% in India?
What are the risk factors for ivig resistance?any recent experience?
Sir
Thanks for an elaborate talk
– Which group would you recommend upfront intensification in KD; as the evidence for benefit in terms of reduction in CAA in a high-risk group is still not robust.
-Thoughts on upfront use of steroids as primary therapy in KD in place of IVIG, particularly for resource-poor settings.
When to use Dexa or Methylprednisolone in HLH mgt?